Finance and efficiency

Reckitt Benckiser fined for anti-competitive activity

By 2010-10-15T10:07:00

Household goods giant Reckitt Benckiser has been fined £10.2m for abusing its dominant position in the supply of its Gaviscon heartburn treatment to the NHS.

Source: Andres Rodriguez - Fotolia

Household goods giant Reckitt Benckiser has been fined £10.2m for abusing its dominant position in the supply of its Gaviscon heartburn treatment to the NHS.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here